- Home
- SYRE vs OCCIM Comparison
SYRE vs OCCIM Comparison
Compare SYRE & OCCIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- OCCIM
- Stock Information
- Founded
- SYRE 2013
- OCCIM N/A
- Country
- SYRE United States
- OCCIM
- Employees
- SYRE N/A
- OCCIM N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- OCCIM
- Sector
- SYRE Health Care
- OCCIM
- Exchange
- SYRE Nasdaq
- OCCIM NYSE
- Market Cap
- SYRE N/A
- OCCIM N/A
- IPO Year
- SYRE 2016
- OCCIM N/A
- Fundamental
- Price
- SYRE $25.34
- OCCIM $25.06
- Analyst Decision
- SYRE Strong Buy
- OCCIM
- Analyst Count
- SYRE 9
- OCCIM 0
- Target Price
- SYRE $48.57
- OCCIM N/A
- AVG Volume (30 Days)
- SYRE 697.8K
- OCCIM N/A
- Earning Date
- SYRE 11-07-2024
- OCCIM N/A
- Dividend Yield
- SYRE N/A
- OCCIM N/A
- EPS Growth
- SYRE N/A
- OCCIM N/A
- EPS
- SYRE N/A
- OCCIM N/A
- Revenue
- SYRE N/A
- OCCIM N/A
- Revenue This Year
- SYRE $168.62
- OCCIM N/A
- Revenue Next Year
- SYRE $47.61
- OCCIM N/A
- P/E Ratio
- SYRE N/A
- OCCIM N/A
- Revenue Growth
- SYRE N/A
- OCCIM N/A
- 52 Week Low
- SYRE $15.37
- OCCIM N/A
- 52 Week High
- SYRE $47.97
- OCCIM N/A
- Technical
- Relative Strength Index (RSI)
- SYRE 39.80
- OCCIM N/A
- Support Level
- SYRE $23.14
- OCCIM N/A
- Resistance Level
- SYRE $27.64
- OCCIM N/A
- Average True Range (ATR)
- SYRE 1.49
- OCCIM 0.00
- MACD
- SYRE -0.04
- OCCIM 0.00
- Stochastic Oscillator
- SYRE 39.27
- OCCIM 0.00
About OCCIM OFS CREDIT COMPANY INC 7.875% PREFERRD STCK SERIES F USD25.0
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.